Published in Am J Respir Cell Mol Biol on September 15, 2005
Global molecular and morphological effects of 24-hour chromium(VI) exposure on Shewanella oneidensis MR-1. Appl Environ Microbiol (2006) 1.04
Health and cellular impacts of air pollutants: from cytoprotection to cytotoxicity. Biochem Res Int (2012) 0.85
The effects of chromium(VI) on the thioredoxin system: implications for redox regulation. Free Radic Biol Med (2012) 0.81
Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol (2011) 0.79
Occupational health assessment of chromite toxicity among Indian miners. Indian J Occup Environ Med (2011) 0.77
Reproductive outcomes after non-occupational exposure to hexavalent chromium, Willits California, 1983-2014. Environ Health (2017) 0.75
PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell (2001) 11.04
PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell (2001) 7.95
DNA excision repair. Annu Rev Biochem (1996) 6.71
PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A (2003) 4.46
The role of apoptosis in cancer development and treatment response. Nat Rev Cancer (2005) 4.19
Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci U S A (2001) 3.16
Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem (1981) 3.01
Lung cancer among workers in chromium chemical production. Am J Ind Med (2000) 2.55
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene (2004) 2.36
A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem (1977) 2.32
One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Ind Med (1990) 2.28
Chromium, nickel and welding. IARC Monogr Eval Carcinog Risks Hum (1990) 2.15
Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res (2003) 2.10
Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res (2004) 1.77
Genotoxicity of chromium compounds. A review. Mutat Res (1990) 1.68
Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000. Hum Exp Toxicol (2001) 1.56
Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog (2002) 1.44
The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol (2001) 1.41
Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res (2004) 1.39
Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol (1996) 1.33
Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit Rev Toxicol (1997) 1.26
Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg (2003) 1.20
Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res (1998) 1.18
Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung. Cancer Res (1983) 1.08
Lung cancer mortality among chromate production workers. Occup Environ Med (2003) 1.07
The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint. Mutat Res (2004) 1.06
Understanding the mechanisms of drug-associated interstitial lung disease. Br J Cancer (2004) 1.05
Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis (2001) 0.96
Function of the alveolar epithelial barrier under pathologic conditions. Chest (1994) 0.95
Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol Carcinog (1998) 0.93
Cell and tissue responses to genotoxic stress. J Pathol (2005) 0.93
Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI). Carcinogenesis (2002) 0.89
DNA single-strand breaks and cytotoxicity induced by sodium chromate(VI) in hydrogen peroxide-resistant cell lines. Mutat Res (1993) 0.88
Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci Total Environ (1988) 0.88
Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000. Am J Ind Med (2002) 0.88
Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol Sci (2000) 0.85
Human papillomavirus type 16 E6-enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell line. Int J Cancer (2002) 0.84
Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site. Biochem Biophys Res Commun (2000) 0.84
Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J Biol Chem (1995) 0.83
c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor. J Pharmacol Exp Ther (2003) 0.83
Retracted Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activation. Cancer (2005) 0.82
Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues. Cancer Res (1985) 0.81
Gene expression during camptothecin-induced apoptosis in human myeloid leukemia cell line ML-2. Neoplasma (2004) 0.78
On the carcinogenicity risk assessment of chromium compounds. Am J Ind Med (2004) 0.76
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol (2009) 2.96
Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J (2003) 2.56
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol (2005) 2.10
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg (2010) 2.08
Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. Int J Cardiol (2011) 2.06
Persistent air leak after pulmonary resection: the water-valve "foam" problem. Ann Thorac Surg (2004) 2.03
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol (2004) 1.83
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J (2004) 1.80
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res (2004) 1.77
Retracted Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med (2009) 1.74
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol (2010) 1.61
Single-centre 40-year results of redo operation for recurrent thymomas. Eur J Cardiothorac Surg (2011) 1.52
Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol (2014) 1.47
Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results. Ann Thorac Surg (2012) 1.46
Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer. Eur J Epidemiol (2010) 1.42
Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem (2009) 1.41
Intrathoracic gastric perforation: a late complication of an unknown postpartum recurrent hiatal hernia. Interact Cardiovasc Thorac Surg (2012) 1.39
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci (2013) 1.32
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys (2010) 1.25
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem (2009) 1.23
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer (2007) 1.21
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis (2011) 1.17
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci (2013) 1.14
Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene (2005) 1.11
Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. J Thorac Oncol (2013) 1.10
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol (2002) 1.09
Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer (2007) 1.08
Are We at the Dusk of Mediastinoscopy in Modern Clinical Practice? J Thorac Oncol (2015) 1.08
N2 nodal involvement in multiple primary lung cancer: really an exclusion criterion? Chest (2013) 1.07
Typical bronchial carcinoid tumors: focus on surgical management. Ann Thorac Surg (2012) 1.07
Peri-operative complications of video-assisted thoracoscopic surgery (VATS). Int J Surg (2008) 1.07
Bronchial carcinoid tumors causing Cushing's syndrome: an insidious disease. Ann Thorac Surg (2013) 1.07
Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07
Surgery and Survival of Patients with Diagnosis of Malignant Pleural Mesothelioma. J Thorac Oncol (2015) 1.07
Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors? Ann Nucl Med (2014) 1.06
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol (2003) 1.05
Role of hypoxia and autophagy in MDA-MB-231 invasiveness. J Cell Physiol (2010) 1.05
Self-selection effects in smokers attending lung cancer screening: a 9.5-year population-based cohort study in Varese, Italy. J Thorac Oncol (2010) 1.02
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia (2013) 1.02
Microdrainage via open technique in severe subcutaneous emphysema. Chest (2003) 1.02
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann Thorac Surg (2012) 1.01
Traumatic diaphragmatic rupture: personal experience. Acta Biomed (2003) 1.01
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Lett (2010) 1.01
The cholinergic system and cancer. Semin Cancer Biol (2007) 1.00
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). Int J Cardiol (2011) 1.00
Successful early treatment of Boerhaave's syndrome by endoscopic placement of a temporary self-expandable plastic stent without fluoroscopy. Gastrointest Endosc (2003) 1.00
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg (2008) 1.00
Chest wall giant lipoma with a thirty-year history. Interact Cardiovasc Thorac Surg (2012) 0.99
Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol (2007) 0.98
Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation (2003) 0.98
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovasc Diabetol (2005) 0.98
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development. Int J Cancer (2008) 0.98
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today (2009) 0.97
Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol (2002) 0.97
Nicotine, lung and cancer. Anticancer Agents Med Chem (2007) 0.97
Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol (2011) 0.96
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol (2014) 0.95
Static magnetic fields enhance skeletal muscle differentiation in vitro by improving myoblast alignment. Cytometry A (2007) 0.95
Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg (2012) 0.95
Post-esophagectomy anastomotic leaks. The role of the anastomotic location. Ann Ital Chir (2013) 0.95
Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference. Chest (2005) 0.94
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med (2015) 0.94
Gender differences in the cardiovascular effects of sex hormones. Fundam Clin Pharmacol (2010) 0.94
Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. Curr Med Chem Anticancer Agents (2004) 0.92
Hormone replacement therapy and cardioprotection: the end of the tale? Ann N Y Acad Sci (2003) 0.92
Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol (2013) 0.92